- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04527913
Interdental Plaque Reduction and Periodontitis
Interdental Plaque Reduction After Use of Different Devices in Patients With Periodontitis: a Randomized Clinical Trial
Study Overview
Status
Conditions
Detailed Description
Patients included in the study will undergo a thorough clinical examination aiming at collecting all the data desired: periodontal parameters of Probing Pocket Depth (PPD), presence of recession of the gingival margin (Rec) and full mouth plaque score (FMPS) will be recorded on six sites/tooth by a single calibrated examiner using a University of North Carolina (UNC) 15-mm periodontal probe by a calibrated examiner blind to group allocation.
Gingival index (GI) and angulated bleeding score (AngBS) will be recorded at four sites/tooth.
For GI the following scale will be used:
0 normal appearance of gingiva, no bleeding, no inflammation;
- slight change and moderate edema with slight change in texture, no bleeding, mild inflammation;
- redness hypertrophy, or edema and glazing, bleeding on probing, moderate inflammation;
- marked redness, hypertrophy, or edema, ulceration, spontaneous bleeding, severe inflammation.
For AngBS the following scale will be used:
0: no bleeding;
- bleeding upon probe stimulation;
- spontaneous bleeding
Consequently, interdental plaque score (IPS), interdental gingival index (IGI), and interdental angulated bleeding score (IAngBI) will be calculated.
Patients will be followed through a five-week period. The timepoints will be the following: T -7 (oral hygiene instructions), T0 (professional supragingival scaling and polishing), T14, T28.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Pisa, Italy, 56121
- University Hospital of Pisa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- males or females of age range between 18 and 70 years,
- good health status,
- presence of at least 20 natural teeth
- residual periodontal pockets with PPD≥4mm, in need of specific oral hygiene regimen.
Exclusion Criteria:
- pregnancy or breast-feeding,
- indication to antibiotic therapy prior to treatment,
- chronic infections,
- systemic diseases (including cardiovascular, pulmonary, cerebral, and metabolic diseases),
- not willing to give a consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control group
15 patients receiving oral hygiene instructions as determined by their group allocation (use of manual toothbrush alone)
|
A session of professional supragingival scaling and polishing: instrumentation will be performed by a trained dental hygienist/periodontist with great care in performing exclusively coronal maneuver.
No instrumentation or exploring of the gingival crevice/ sulcus will be performed.
OHI will be given focusing on manual toothbrushing and will be given only once at timepoint T-7. No further formal OH instructions will be given, unless specifically asked by the patient. OHI will be delivered by trained dental hygienist/periodontist. |
|
Experimental: Test group 1
15 patients receiving oral hygiene instructions as determined by their group allocation (manual toothbrush plus dental floss)
|
A session of professional supragingival scaling and polishing: instrumentation will be performed by a trained dental hygienist/periodontist with great care in performing exclusively coronal maneuver.
No instrumentation or exploring of the gingival crevice/ sulcus will be performed.
OHI will be given focusing on manual toothbrushing and will be given only once at timepoint T-7. No further formal OH instructions will be given, unless specifically asked by the patient. OHI will be delivered by trained dental hygienist/periodontist. Int-OHI will be given focusing on the interdental device of the allocated group for each patient and will be given only once at timepoint T-7. No further formal Int-OH instructions will be given, unless specifically asked by the patient. Int-OHI will be delivered by trained dental hygienist/periodontist. |
|
Experimental: Test group 2
15 patients receiving oral hygiene instructions as determined by their group allocation (manual toothbrush plus interdental brushes)
|
A session of professional supragingival scaling and polishing: instrumentation will be performed by a trained dental hygienist/periodontist with great care in performing exclusively coronal maneuver.
No instrumentation or exploring of the gingival crevice/ sulcus will be performed.
OHI will be given focusing on manual toothbrushing and will be given only once at timepoint T-7. No further formal OH instructions will be given, unless specifically asked by the patient. OHI will be delivered by trained dental hygienist/periodontist. Int-OHI will be given focusing on the interdental device of the allocated group for each patient and will be given only once at timepoint T-7. No further formal Int-OH instructions will be given, unless specifically asked by the patient. Int-OHI will be delivered by trained dental hygienist/periodontist. |
|
Experimental: Test group 3
15 patients receiving oral hygiene instructions as determined by their group allocation (manual toothbrush plus rubber interdental picks)
|
A session of professional supragingival scaling and polishing: instrumentation will be performed by a trained dental hygienist/periodontist with great care in performing exclusively coronal maneuver.
No instrumentation or exploring of the gingival crevice/ sulcus will be performed.
OHI will be given focusing on manual toothbrushing and will be given only once at timepoint T-7. No further formal OH instructions will be given, unless specifically asked by the patient. OHI will be delivered by trained dental hygienist/periodontist. Int-OHI will be given focusing on the interdental device of the allocated group for each patient and will be given only once at timepoint T-7. No further formal Int-OH instructions will be given, unless specifically asked by the patient. Int-OHI will be delivered by trained dental hygienist/periodontist. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FMPS Full-mouth plaque score (FMPS)
Time Frame: Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks
|
Changes in FMPS, measured orally through clinical examination.
Unit of measure: N
|
Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pocket probing depth (PPD)
Time Frame: Measured at Baseline and at 5 weeks
|
Changes in PPD, measured orally through clinical examination.
Unit of measure: mm
|
Measured at Baseline and at 5 weeks
|
|
Recession of the gingival margin (REC)
Time Frame: Measured at Baseline and at 5 weeks
|
Changes in REC, measured orally through clinical examination.
Unit of measure: mm
|
Measured at Baseline and at 5 weeks
|
|
Clinical attachment level (CAL)
Time Frame: Measured at Baseline and at 5 weeks
|
Changes in CAL, measured orally through clinical examination.
Unit of measure: mm
|
Measured at Baseline and at 5 weeks
|
|
Gingival Index (GI)
Time Frame: Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks
|
Changes in GI, measured orally through clinical examination.
Unit of measure: scale from 0 (normal) to 3 (Marked redness, hypertrophy, or edema, ulceration)
|
Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks
|
|
Angulated bleeding score (AngBS)
Time Frame: Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks
|
Changes in AngBS, measured orally through clinical examination.
Unit of measure: scale from 0 (no bleeding), 1 (bleeding upon probe stimulation) to 2 (spontaneous bleeding).
|
Measured at: Baseline, at 1 week, at 3 weeks, and at 5 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Periobrush
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruitingPeriodontitis Stage II | Periodontitis Stage III | Periodontitis Stage IV
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Al-Azhar UniversityNot yet recruitingStage IV Periodontitis | Advanced Periodontitis | Stage III PeriodontitisEgypt
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
University Hospital HeidelbergRecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IVGermany
-
Akdeniz UniversityNot yet recruitingPeriodontitis (Stage 3) | Periodontitis Stage IVTurkey (Türkiye)
-
Gülnur EmingilEge University Scientific Research Projects Coordination UnitCompletedPeriodontitis (Stage 3) | Periodontitis Stage IIITurkey (Türkiye)
Clinical Trials on One session of professional supragingival scaling and polishing
-
University of PisaCompleted
-
Al-Azhar UniversityRecruitingChildren | Dental Plaque | Streptococcus Mutans | Mouthwashes | Probiotic | Salivary pH | Ethyl Lauroyl ArginateEgypt
-
NYU Langone HealthWithdrawn
-
Universidad Complutense de MadridInstituto de Salud Carlos IIITerminated
-
University of Santiago de CompostelaUnknownPeriodontitis | Gingivitis | Oral BiofilmSpain
-
University Hospital of North NorwayNorwegian University of Science and TechnologyCompleted
-
Fred Hutchinson Cancer CenterBreast Cancer Research FoundationCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Hospices Civils de LyonUnknown